Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-24-005860
Filing Date
2024-05-21
Accepted
2024-05-21 10:37:38
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27651
2 filename2.txt TEXT-EXTRACT 1480
  Complete submission text file 0000000000-24-005860.txt   40357
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filed for) CIK: 0001488039 (see all company filings)

EIN.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD | File No.: 333-279367
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)